15-76932388-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002902.3(RCN2):c.172G>A(p.Gly58Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002902.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RCN2 | NM_002902.3 | c.172G>A | p.Gly58Ser | missense_variant | 2/7 | ENST00000394885.8 | |
RCN2 | NM_001271837.2 | c.172G>A | p.Gly58Ser | missense_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RCN2 | ENST00000394885.8 | c.172G>A | p.Gly58Ser | missense_variant | 2/7 | 1 | NM_002902.3 | P1 | |
RCN2 | ENST00000320963.9 | c.172G>A | p.Gly58Ser | missense_variant | 2/8 | 5 | |||
RCN2 | ENST00000394883.3 | c.144+403G>A | intron_variant | 5 | |||||
RCN2 | ENST00000557805.1 | c.145G>A | p.Gly49Ser | missense_variant, NMD_transcript_variant | 2/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251136Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135768
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461608Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727106
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74280
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2023 | The c.172G>A (p.G58S) alteration is located in exon 2 (coding exon 2) of the RCN2 gene. This alteration results from a G to A substitution at nucleotide position 172, causing the glycine (G) at amino acid position 58 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at